RxDoctor Payments Data

Henry Nagelberg, MD

Ophthalmology · Branchburg, NJNPI 1952307969

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.4%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Alcon at 55.4% of the total. Reporting peaked in 2021 at $568 and has fallen 94.0% since, to $34 in 2025. That places this record below the midpoint for ophthalmology clinicians in NJ, where the typical reported total is $1,407.

$903in general payments, 2019–2025

Across 21 payments — averaging $43.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$500
  • Johnson & Johnson Vision Care, Inc.$254
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$71
  • Novartis$27
  • Carl Zeiss Meditec AG$19
  • Bausch & Lomb Americas Inc.$18
  • plus $14 from 1 others

What the payments were for

  • Speaking & faculty fees$50055%
  • Food & beverage$36641%
  • Education$182%
  • Gifts$192%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$903 in reported general payments places this provider in the 35th percentile of 583 ophthalmology providers in New Jersey.

See all ophthalmology providers in New Jersey →

Medicare billing

Part B allowed, 2024
$118,819
Medicare patients
721
Services billed
1,001

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine32$35,577
LumiganBimatoprost15$10,286
Alphagan PBrimonidine Tartrate11$7,774
Brimonidine Tartrate11$3,709
Latanoprost99$1,579
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat27$1,047
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha59$609
Timolol Maleate45$600
Doxycycline Hyclate36$287
ErythromycinErythromycin Base22$230

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Branchburg

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →